Loading...
Coya Therapeutics Inc (COYA) is not a strong buy for a beginner, long-term investor at this moment. The stock lacks clear positive catalysts, has weak financial performance, and no significant trading signals or trends to support immediate investment. While technical indicators are neutral to slightly positive, the overall sentiment and fundamentals do not justify a buy decision for a long-term strategy.
The MACD is positive and expanding, indicating a slight bullish momentum. RSI is neutral at 56.217, suggesting no overbought or oversold conditions. Moving averages are converging, showing no clear trend. The stock is trading close to its pivot level of 4.838, with key resistance at 5.186 and support at 4.491.

NULL identified. No recent news or significant insider/hedge fund activity. Technical indicators are neutral to slightly positive.
Weak financial performance with declining EPS (-50% YoY) and net income (-47.39% YoY). High bearish sentiment in the options market. Lack of significant trading signals or trends.
In Q3 2025, revenue remained flat at $3,564,254 (0% YoY growth). Net income dropped significantly to -$2,115,831 (-47.39% YoY), and EPS fell to -0.13 (-50% YoY). Gross margin remained stable at 100%. The company is struggling with profitability.
No analyst ratings or price target changes provided. Lack of Wall Street sentiment data.